A novel PLK1 inhibitor onvansertib effectively sensitizes MYC-driven medulloblastoma to radiotherapy.
Wang D, Veo B, Pierce A, Fosmire S, Madhavan K, Balakrishnan I, Donson A, Alimova I, Sullivan KD, Joshi M, Erlander M, Ridinger M, Foreman NK, Venkataraman S, Vibhakar R.
Wang D, et al. Among authors: vibhakar r.
Neuro Oncol. 2022 Mar 12;24(3):414-426. doi: 10.1093/neuonc/noab207.
Neuro Oncol. 2022.
PMID: 34477871
Free PMC article.